KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Staar Surgical (STAA) EBIAT (2016 - 2026)

Staar Surgical's EBIAT history spans 17 years, with the latest figure at -$18.3 million for Q1 2026.

  • For Q1 2026, EBIAT rose 46.51% year-over-year to -$18.3 million; the TTM value through Jan 2026 reached -$80.4 million, down 298.1%, while the annual FY2026 figure was -$80.4 million, 298.1% down from the prior year.
  • EBIAT reached -$18.3 million in Q1 2026 per STAA's latest filing, down from $8.9 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $13.0 million in Q3 2022 to a low of -$54.2 million in Q1 2025.
  • Average EBIAT over 5 years is -$2.5 million, with a median of $6.4 million recorded in 2022.
  • Peak YoY movement for EBIAT: skyrocketed 107.18% in 2024, then crashed 1523.57% in 2025.
  • A 5-year view of EBIAT shows it stood at $6.8 million in 2022, then increased by 14.68% to $7.8 million in 2023, then tumbled by 541.31% to -$34.2 million in 2024, then skyrocketed by 125.96% to $8.9 million in 2025, then tumbled by 306.09% to -$18.3 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's EBIAT are -$18.3 million (Q1 2026), $8.9 million (Q3 2025), and -$16.8 million (Q2 2025).